Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 vs PCV7 in Healthy Infants
NCT00373958Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2006
- Primary completion
- Jun 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Prevnar 13 in pneumococcal infection, sponsored by Pfizer. Started Sep 2006; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00373958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373958.